Solid-phase synthesis of benzisothiazolones as serine protease inhibitors
- 1 March 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (5) , 663-666
- https://doi.org/10.1016/s0960-894x(99)00078-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 1,2-Benzisothiazol-3-one 1,1-Dioxide Inhibitors of Human Mast Cell TryptaseJournal of Medicinal Chemistry, 1998
- Potent and Specific Inhibition of Human Leukocyte Elastase, Cathepsin G and Proteinase 3 by Sulfone Derivatives Employing the 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide ScaffoldBioorganic & Medicinal Chemistry, 1998
- Secondary amide-based linkers for solid phase organic synthesisTetrahedron Letters, 1997
- Trytase inhibitors: a new class of antiinflammatory drugsDrugs of the Future, 1996
- Radiofrequency Encoded Combinatorial ChemistryAngewandte Chemie International Edition in English, 1995
- A Novel Class of Cyclic .beta.-Dicarbonyl Leaving Groups and Their Use in the Design of Benzisothiazolone Human Leukocyte Elastase InhibitorsJournal of Medicinal Chemistry, 1995
- Orally Bioavailable Benzisothiazolone Inhibitors of Human Leukocyte ElastaseJournal of Medicinal Chemistry, 1995
- Reductive alkylation on a solid phase: Synthesis of a piperazinedione combinatorial libraryBioorganic & Medicinal Chemistry Letters, 1995
- 2,6-Disubstituted Aryl Carboxylic Acids, Leaving Groups "Par Excellence" for Benzisothiazolone Inhibitors of Human Leukocyte ElastaseJournal of Medicinal Chemistry, 1994